Movatterモバイル変換


[0]ホーム

URL:


US3826241A - Implanting method - Google Patents

Implanting method
Download PDF

Info

Publication number
US3826241A
US3826241AUS00298024AUS29802472AUS3826241AUS 3826241 AUS3826241 AUS 3826241AUS 00298024 AUS00298024 AUS 00298024AUS 29802472 AUS29802472 AUS 29802472AUS 3826241 AUS3826241 AUS 3826241A
Authority
US
United States
Prior art keywords
tissue
recited
exterior surface
predetermined location
exterior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00298024A
Inventor
L Bucalo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Investors in Ventures Inc
Original Assignee
Investors in Ventures Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Investors in Ventures IncfiledCriticalInvestors in Ventures Inc
Priority to US00298024ApriorityCriticalpatent/US3826241A/en
Application grantedgrantedCritical
Publication of US3826241ApublicationCriticalpatent/US3826241A/en
Anticipated expirationlegal-statusCritical
Expired - Lifetimelegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Abstract

A method for implanting artificial devices in the bodies of living creatures such as human beings. The device is initially embedded in tissue of the living creature where the device is permitted to remain until ingrowth of tissue into intimate contact with the exterior surface of the device is completed. Then the device is removed while retaining thereon a layer of the tissue which has grown into contact with the device, and the device with this layer of tissue thereon is then implanted in the body at the location where the device is to be used in the body with tissue at this latter part of the body engaging the tissue which has previously grown onto the device, so that the possibility of rejection of the device is reduced.

Description

United States Patent 1191 Bucalo [11] 3,826,241 1451 July 30,1974
[ IMPLANTING METHOD Primary ExaminerRichard A. Gaudet [7,5] Lows f Holbrook Assistant Examiner-Ronald L. Frinks Asslgneei Investors In Ventures, n New Attorney, Agent, or Firm-Steinberg & Blake York, NY. [22] Filed: Oct. 16, 1972 [57] ABSTRACT [21] App]. No.2 298,024 A method for implanting artificial devices in the bodies of living creatures such as human beings. The device is initially embedded in tissue of the living crea- [52] US. Cl. 128/1 R, 3/1, 128/92 C, tut-e where the device is permitted to remain um 128/334 128/419 32/10 A growth of tissue into intimate contact with the exterior [51] lltt. C1. A6" 1/24, A6lb 19/00 Surface of the device is completed Then the device is [58] Flew Search-m BIG 3; 128/1 334R removed while retaining thereon a layer of the tissue 128/92 92 419 P; 32/10 A which has grown into contact with the device, and the 1 device with this layer of tissue thereon is then im- [56] References a planted in the body at the location where the device is UNITED STATES PATENTS to be. used in the body with tissue at this latter part of 3,514,791 6/1970 the body engaging the tissue which has previously 3,546,711 12/1970 grown onto the device, so that the possibility of rejec- 3,699,957 10/1972 Robinson 128/] R tion of the device is reduced. 3,704,704 l2/l972 Gonzales l28/l R 3.710.777 1/1973 Sparks l28/l R 9 Claims, 4 Drawing Figures R 32 i LU Pmmwwwm 3.826.241
III 111111111110 g 1 Y I IMPLANTING METHOD- BACKGROUND OF THE INVENTION The present invention relates to the implanting of devices in the bodies of living creatures such'as human beings.
As is well known, it is advisable and necessary under certain conditions to introduce an artificial implant device into the body of a living creature such as a human being. Such devices may take many different forms. For example pacemakers may be implanted to control the operations of the heart. An artificial heart itself may be implanted. Artificial bones or parts of bones, including artificial teeth, may be implanted. Valves may be implanted to control the flow of body fluids.
One of the major problems encountered when dealing with implants is that in many cases the body rejects the implant. Although great care may be exercised in the choice of the materials used for the device which is to be implanted, the number of different materials which are known to be compatible with human tissue is extremely small, and when a compatible material, such as gold, is used, the costs are extremely high.
A further problem encountered in connection with implants is the reliability of the anchoring of the implant of the desired location. After a given device has been implanted it may undesirably move from its initial location. Furthermore, where a seal is required between the exterior surface of the implanted device and the tissue of the body, as is the case with valves, for example, such a seal can not always be reliably achieved.
SUMMARY OF THE INVENTIONv It is accordingly a primary object of the present invention to provide a method for avoiding the above drawbacks.
In particular, it is an object of the present invention to provide an implanting method which will greatly reduce the possibility of rejection of the implanted deprovide a method of this type which is easy to perform at a relatively low cost and without any particular danger to the individual who is to receive the implant.
Yet another object of the present invention is to provide a method which enables implanting of a device in such a way that not only is the possibility of rejection greatly reduced but in addition the device will be reliably anchored at the desired location in a manner which will reliably avoid undesirable movement of the device and leakage of body fluids along the exterior of the device.
According to the method of the invention the device which is to be implanted is initially embedded in tissue of the body which is ultimately to receive the device, with this latter tissue being located at a part of the body different from the predetermined location which ultimately receives the device. The embedded device is permitted to remain in the tissue in which his initially placed for a length of time sufficient to permit ingrowth of tissue into intimate contact with the exterior surface of the device. Then the device is removed from the body while retaining on the device a layer of the tissue which has grown into contact with the exterior surface of the device. This device with the layer of tissuewhich has grown thereon is then implanted in the body at the predetermined location where tissue of the body is placed directly in contact with the tissue previously grown onto the device so that it is only required forthe tissue at the ultimate location of the device to become united with tissue already grown onto the device in the same body in which the device is ultimately implanted, thus reducing the possibility of rejection.
BRIEF DESCRIPTION OF DRAWINGS first step in FIG. 4 is a schematic .representation of the manner in which a device in the condition shown in FIG. 3 is implanted at its ultimate location in the body.
DESCRIPTION OF PREFERRED EMBODIMENTS Referring to FIG. 1, there is illustrated therein thedevice 10 which is to be implanted in the body of a living creature such as a human being. In the illustrated example thisdevice 10 is a valve, but it is to be understood that any artificial device may be treated according to the present invention, such as pacemakers, artificial organs, artificial bones or parts thereof, teeth, etc.
' FIG. 1 schematically represents apart 12 of the body of a human being, thispart 12 being composed of a body oftissue 14 covered with exterior skin l6. Thetissue 14 is preferably located at a part of the body where a relatively large amount of such tissue is readily accessible at theexterior skin 16. For example a buttock is particularly suitable for this purpose.
According to the first step of the method of the invention anincision 18 is made through theskin 16 into thetissue 14 so as to form in the tissue 14 apocket 20 by stretching the tissue andskin 16 at the region of theincision 18 in the manner shown schematically in FIG. 1. Thepocket 20 is of course made somewhat larger than thedevice 10 so that through theincision 18 thedevice 10 can be readily introduced into thepocket 20. Then theincision 18 is closed and sutures may be applied for this purpose, so that thedevice 10 remains embedded in thetissue 14 as indicated schematically in FIG. 2. Thedevice 10 can remain in this condition shown in FIG. 2 in the body of an individual without creating any particular problems or any particular discomfort, and during a period of time which may be on the order of two or three months, the ingrowth of thetissue 14 will take place into intimate contact with the exterior surface of thedevice 10. For this purpose, an individual may go to a hospital for no more than overnight stay, so that the surgeon can embed thedevice 10 in thetissue 14. Then the individual may leave the hospital and go about his business in a usual manner for a period of two or three months, until ingrowth of tissue has been completed.
In order to promote ingrowth of tissue it is possible to situate at the exterior of thedevice 10, prior to embedding thereof in thetissue 14, ameans 22 which will promote the ingrowth of tissue. In the example illustrated in FIG. 1 this means takes the form of one or more strands of gold wire wound around the valve at the exterior thereof to form a large number of interstices through which the tissue will grow into intimate contact with the exterior surface of thedevice 10. Other structures may be used to form themeans 22 for promoting the ingrowth 'of tissue. For example any layer of porous material such as gold sprayed onto the exterior surface of thedevice 10 in a suitable evacuated atmosphere may be used.
After the period required for completion of ingrowth of tissue has elapsed, the individual returns to the hospital and the surgeon will remove thedevice 10 from thetissue 14 in which it was initially embedded. At this stage of the method of the invention the surgeon is careful to leave on the device 10 alayer 24 of the tissue which has grown into intimate contact with the exterior surface of thedevice 10. In the particular example shown in the drawings where a valve is used for thedevice 10, anoperating component 26 of the valve may be left exposed so that the valve can be opened and closed. However, when dealing with other types of devices such exposure of part of the device may not be required. It is to be noted that in accordance with the invention any of the artificial devices which are to be implanted have exterior surfaces which are impervious to tissue so that tissue cannot grow into the device beyond the exterior surface thereof.
Immediately subsequent to the removal of thedevice 10 from thetissue 14 with thelayer 24 of ingrown tissue remaining on thedevice 10, only at the exteriorsurface thereof, the surgeon will introduce thedevice 10 into the part of the body where the device is to remain. Thus, FIG. 4 shows by way of example, in a schematic manner, avas deferens 28 initially formed in a wall portion thereof with a slit 30 through which thedevice 10 with theingrown tissue 24 thereon is introduced in the manner shown in FIG. 4.
With this method theinner tissue 32 which lines the cavity formed by the interior of thevas 28 directly engages only theingrown tissue 24 from the very same individual in which thedevice 10 is implanted. It is thus required that thetissue 32 become united only withtissue 24, and since thetissue 32 and thetissue 24 are from the same individual the possibility of rejection is very greatly reduced. In addition, the uniting of thetissue 32 with thetissue 24 by ingrowth of thetissue 32 into intimate union with thetissue 24 reliably anchors thedevice 10 at the desired location and in the case of a valve reliably prevents any leakage past the valve at the exterior thereof. Of course, in the case of a valve care is taken to maintain theends 36 and 38 of the valve open so that the flow of fluids can readily be controlled by opening and closing of the valve.
Of course, after thedevice 10 is removed with thetissue 24 remaining thereon, the second incision which is made is again closed so that thepart 12 of the body where thetissue 14 is located will heal up readily.
It is emphasized that the method of the invention is illustrated above in connection with a valve only by way of example. The method of the invention is applicable to all types of devices which are to be implanted in the body of a living creature such as a human being. For example in FIG. 4 the tubes connected to the device may be arteries connected to an artificial heart. As was pointed out above pacemakers may be treated in the manner indicated above so as to be reliably retained in the body without any possibility of rejection. Furthermore the method of the invention may be practiced with any artificial materials or devices such as a section of artificial bone which is to be introduced, a tooth which is to be implanted in gums, or even tubes, plates, or the like which are to be used to repair injuries to any body cavities.
What is claimed is:
1. In a method for implanting in the body of a living creature such as a human being an artificial implant device which has an exterior surface which is impervious to the growth of tissue so that tissue cannot grow into the device beyond the exterior surface thereof, the steps of initially embedding the device in tissue of the living creature at a location different from a predetermined location at which the device is ultimately to be located and remain, while exposing only the exterior surface of the device to the tissue and permitting the device to remain in the tissue in which it is initially embedded until ingrowth of tissue into intimate contact only with the exterior surface of the device is completed, then removing the device from the location at which it was initially embedded while retaining only at the exterior of the device tissue which has grown into contact only with the exterior surface of the device, and then surgically obtaining access to said predetermined location and implanting the device with the tissue thereon only at the exterior surface thereof at said predetermined location with the tissue at the exterior of the device engaging tissue located at said predetermined location, and then surgically closing off access to said predetermined location so that at said predetermined location tissue of the body need only become united with tissue of the same body, whereby the possibility of rejection of the device is reduced.
2. A method as recited in claim 1 and including the step of preliminarily locating at the exterior surface of the device, prior to initial embedding thereof, a means which will permit the ingrowth of tissue.
3. A method as recited in claim 1 and wherein the tissue is initially embedded at a part of the body where a relatively large volume of tissue is readily accessible from the exterior of the body.
4. A method as recited in claim 3 and wherein the part of the body where the device is initially embedded is a buttock.
5. A method as recited in claim 1 and wherein said predetermined location is the interior of a body cavity which is lined with tissue placed in engagement with the tissue preliminarily grown onto the device and retained thereon when the device is removed from the location at which it is initially embedded.
6. A method as recited in claim 5 and wherein the cavity is the interior of a vas deferens of human male and the device is a valve.
7. A method as recited in claim 6 and wherein wire is preliminarily wound onto the exterior of the valve prior to initial embedding thereof for promoting ingrowth of tissue.
8. A method as recited in claim 1 and wherein the device is a valve.
9. A method as recited in claim 1 and wherein the device is implanted at said predetermined location immediately subsequent to removal of the device from the location at which it was initially embedded.
* x: a a m

Claims (9)

1. In a method for implanting in the body of a living creature such as a human being an artificial implant device which has an exterior surface which is impervious to the growth of tissue so that tissue cannot grow into the device beyond the exterior surface thereof, the steps of initially embedding the device in tissue of the living creature at a location different from a predetermined location at which the device is ultimately to be located and remain, while exposing only the exterior surface of the device to the tissue and permitting the device to remain in the tissue in which it is initially embedded until ingrowth of tissue into intimate contact only with the exterior surface of the device is completed, then removing the device from the location at which it was initially embedded while retaining only at the exterior of the device tissue which has grown into contact only with the exterior surface of the device, and then surgically obtaining access to said predetermined location and implanting the device with the tissue thereon only at the exterior surface thereof at said predetermined location with the tissue at the exterior of the device engaging tissue located at said predetermined location, and then surgically closing off access to said predetermined location so that at said predetermined location tissue of the body need only become united with tissue of the same body, whereby the possibility of rejection of the device is reduced.
US00298024A1972-10-161972-10-16Implanting methodExpired - LifetimeUS3826241A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
US00298024AUS3826241A (en)1972-10-161972-10-16Implanting method

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
US00298024AUS3826241A (en)1972-10-161972-10-16Implanting method

Publications (1)

Publication NumberPublication Date
US3826241Atrue US3826241A (en)1974-07-30

Family

ID=23148681

Family Applications (1)

Application NumberTitlePriority DateFiling Date
US00298024AExpired - LifetimeUS3826241A (en)1972-10-161972-10-16Implanting method

Country Status (1)

CountryLink
US (1)US3826241A (en)

Cited By (28)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4263681A (en)*1977-06-021981-04-28Johnson, Matthey & Co., LimitedCoated metallic bone joint prosthesis resistant to synovial fluid corrosion
US4355428A (en)*1976-07-021982-10-26S.A. Benoist Girard & CieSurgical prosthesis with grainy surface
US4372317A (en)*1975-10-241983-02-08Look International Enterprises, Inc.Method of installing a scalp anchor for a hairpiece
US4439152A (en)*1982-03-041984-03-27Small Irwin AMethod of jawbone abutment implant for dental prostheses and implant device
US4492577A (en)*1982-10-251985-01-08Farris Edward TSurgical implants with solid interiors and porous surfaces
US4520821A (en)*1982-04-301985-06-04The Regents Of The University Of CaliforniaGrowing of long-term biological tissue correction structures in vivo
WO1985005548A1 (en)*1984-05-311985-12-19Adrian KantrowitzPercutaneous access device and method for implanting same
US5242415A (en)*1992-08-141993-09-07L-Vad Technology, Inc.Percutaneous access device
US5567612A (en)*1986-11-201996-10-22Massachusetts Institute Of TechnologyGenitourinary cell-matrix structure for implantation into a human and a method of making
US5709854A (en)*1993-04-301998-01-20Massachusetts Institute Of TechnologyTissue formation by injecting a cell-polymeric solution that gels in vivo
US5716404A (en)*1994-12-161998-02-10Massachusetts Institute Of TechnologyBreast tissue engineering
US5741685A (en)*1995-06-071998-04-21Children's Medical Center CorporationParenchymal cells packaged in immunoprotective tissue for implantation
US5770417A (en)*1986-11-201998-06-23Massachusetts Institute Of Technology Children's Medical Center CorporationThree-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo
US5804178A (en)*1986-11-201998-09-08Massachusetts Institute Of TechnologyImplantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue
US5833655A (en)*1997-05-151998-11-10L. Vad Technology, Inc.Percutaneous access device having removable turret assembly
US5851833A (en)*1991-10-241998-12-22Children's Medical Center Corp.Neomorphogenesis of urological structures in vivo from cell culture
US5855610A (en)*1995-05-191999-01-05Children's Medical Center CorporationEngineering of strong, pliable tissues
US5868764A (en)*1996-12-121999-02-09Cornell Research Foundation, Inc.Perfusion and occlusion device and method
US6129761A (en)*1995-06-072000-10-10Reprogenesis, Inc.Injectable hydrogel compositions
US6132363A (en)*1997-09-302000-10-17L.Vad Technology, Inc.Cardiovascular support control system
US6216570B1 (en)1999-01-052001-04-17L. Vad Technology, Inc.Driver for captively holding a fastener during assembly and disassembly of two parts
US6309635B1 (en)1986-11-202001-10-30Children's Medical Center Corp.Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo
US6322536B1 (en)1998-03-062001-11-27Cornell Research Foundation, Inc.Minimally invasive gene therapy delivery and method
US6508802B1 (en)2000-05-232003-01-21Cornell Research Foundation, Inc.Remote sensing gene therapy delivery device and method of administering a therapeutic solution to a heart
US6511412B1 (en)1998-09-302003-01-28L. Vad Technology, Inc.Cardivascular support control system
US6735532B2 (en)1998-09-302004-05-11L. Vad Technology, Inc.Cardiovascular support control system
US6840962B1 (en)1995-05-012005-01-11Massachusetts Institute Of TechnologyTissue engineered tendons and ligaments
US7468050B1 (en)2002-12-272008-12-23L. Vad Technology, Inc.Long term ambulatory intra-aortic balloon pump

Citations (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3514791A (en)*1967-07-251970-06-02Charles H SparksTissue grafts
US3546711A (en)*1968-04-091970-12-15Gulf Energy & Environ SystemsHeart valve
US3699957A (en)*1970-10-011972-10-24Tecna CorpVas prosthesis for reversible sterilization
US3704704A (en)*1970-10-121972-12-05Ramon L GonzalesBirth control valve
US3710777A (en)*1970-12-231973-01-16C SparksMethod and apparatus for growing graft tubes in place

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3514791A (en)*1967-07-251970-06-02Charles H SparksTissue grafts
US3546711A (en)*1968-04-091970-12-15Gulf Energy & Environ SystemsHeart valve
US3699957A (en)*1970-10-011972-10-24Tecna CorpVas prosthesis for reversible sterilization
US3704704A (en)*1970-10-121972-12-05Ramon L GonzalesBirth control valve
US3710777A (en)*1970-12-231973-01-16C SparksMethod and apparatus for growing graft tubes in place

Cited By (37)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4372317A (en)*1975-10-241983-02-08Look International Enterprises, Inc.Method of installing a scalp anchor for a hairpiece
US4355428A (en)*1976-07-021982-10-26S.A. Benoist Girard & CieSurgical prosthesis with grainy surface
US4263681A (en)*1977-06-021981-04-28Johnson, Matthey & Co., LimitedCoated metallic bone joint prosthesis resistant to synovial fluid corrosion
US4439152A (en)*1982-03-041984-03-27Small Irwin AMethod of jawbone abutment implant for dental prostheses and implant device
US4520821A (en)*1982-04-301985-06-04The Regents Of The University Of CaliforniaGrowing of long-term biological tissue correction structures in vivo
US4492577A (en)*1982-10-251985-01-08Farris Edward TSurgical implants with solid interiors and porous surfaces
WO1985005548A1 (en)*1984-05-311985-12-19Adrian KantrowitzPercutaneous access device and method for implanting same
US4634422A (en)*1984-05-311987-01-06Adrian KantrowitzPercutaneous access device and method for implanting same
US5804178A (en)*1986-11-201998-09-08Massachusetts Institute Of TechnologyImplantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue
US5770417A (en)*1986-11-201998-06-23Massachusetts Institute Of Technology Children's Medical Center CorporationThree-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo
US6309635B1 (en)1986-11-202001-10-30Children's Medical Center Corp.Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo
US5567612A (en)*1986-11-201996-10-22Massachusetts Institute Of TechnologyGenitourinary cell-matrix structure for implantation into a human and a method of making
US5851833A (en)*1991-10-241998-12-22Children's Medical Center Corp.Neomorphogenesis of urological structures in vivo from cell culture
US5242415A (en)*1992-08-141993-09-07L-Vad Technology, Inc.Percutaneous access device
US5709854A (en)*1993-04-301998-01-20Massachusetts Institute Of TechnologyTissue formation by injecting a cell-polymeric solution that gels in vivo
US7807150B2 (en)1993-04-302010-10-05Massachusetts Institute Of TechnologyInjectable composition containing crosslinkable material and cells for forming animal tissue
US20040170612A1 (en)*1993-04-302004-09-02Griffith Linda G.Injectable polysaccharide-cell compositions
US5716404A (en)*1994-12-161998-02-10Massachusetts Institute Of TechnologyBreast tissue engineering
US7914579B2 (en)1995-05-012011-03-29Children's Medical Center CorporationTissue engineered tendons and ligaments
US20070005139A1 (en)*1995-05-012007-01-04Vacanti Charles ATissue engineered tendons and ligaments
US20050060033A1 (en)*1995-05-012005-03-17Vacanti Charles A.Tissue engineered tendons and ligaments
US6840962B1 (en)1995-05-012005-01-11Massachusetts Institute Of TechnologyTissue engineered tendons and ligaments
USRE42479E1 (en)1995-05-192011-06-21Children's Medical Center CorporationEngineering of strong, pliable tissues
US5855610A (en)*1995-05-191999-01-05Children's Medical Center CorporationEngineering of strong, pliable tissues
USRE42575E1 (en)1995-05-192011-07-26Children's Medical Center CorporationEngineering of strong, pliable tissues
US6348069B1 (en)1995-05-192002-02-19Children's Medical Center CorporationEngineering of strong, pliable tissues
US6129761A (en)*1995-06-072000-10-10Reprogenesis, Inc.Injectable hydrogel compositions
US5741685A (en)*1995-06-071998-04-21Children's Medical Center CorporationParenchymal cells packaged in immunoprotective tissue for implantation
US5868764A (en)*1996-12-121999-02-09Cornell Research Foundation, Inc.Perfusion and occlusion device and method
US5833655A (en)*1997-05-151998-11-10L. Vad Technology, Inc.Percutaneous access device having removable turret assembly
US6132363A (en)*1997-09-302000-10-17L.Vad Technology, Inc.Cardiovascular support control system
US6322536B1 (en)1998-03-062001-11-27Cornell Research Foundation, Inc.Minimally invasive gene therapy delivery and method
US6735532B2 (en)1998-09-302004-05-11L. Vad Technology, Inc.Cardiovascular support control system
US6511412B1 (en)1998-09-302003-01-28L. Vad Technology, Inc.Cardivascular support control system
US6216570B1 (en)1999-01-052001-04-17L. Vad Technology, Inc.Driver for captively holding a fastener during assembly and disassembly of two parts
US6508802B1 (en)2000-05-232003-01-21Cornell Research Foundation, Inc.Remote sensing gene therapy delivery device and method of administering a therapeutic solution to a heart
US7468050B1 (en)2002-12-272008-12-23L. Vad Technology, Inc.Long term ambulatory intra-aortic balloon pump

Similar Documents

PublicationPublication DateTitle
US3826241A (en)Implanting method
Hardwick et al.Devices for dentoalveolar regeneration: an up‐to‐date literature review
Sauvage et al.Future directions in the development of arterial prostheses for small and medium caliber arteries
Scantlebury1982‐1992: A decade of technology development for guided tissue regeneration
JP5091383B2 (en) Bioabsorbable inflatable device, dissection instrument and method for expanding and regenerating tissue
US7004977B2 (en)Soft tissue substitute and method of soft tissue reformation
BarteeThe use of high-density polytetrafluoroethylene membrane to treat osseous defects: clinical reports
US5727945A (en)Impregnated barrier and method of assisting bone or tissue regeneration
US3924274A (en)An adjunct and method for facilitating implantation of joint prostheses
JP2905592B2 (en) Methods and articles for treating periodontal diseases and bone defects
US5556427A (en)Orbital implant and method
US6019764A (en)Method of treating alveolar bone defects
Akagawa et al.Tissue reaction to implanted biomaterials
US5713955A (en)Orbital implant
JPS61502866A (en) Periodontal disease treatment supplies
BeekhuisAugmentation mentoplasty with polyamide mesh: update
McCollough et al.Augmentation mentoplasty using Mersilene mesh
BRPI0820449B1 (en) Medical implant set for a host
CA1118155A (en)Implant device of bio-compatible carbon substrate coated with collagen
DE4040872A1 (en)Implantable tissue support carrying artificially cultivated cells - and resembling desmodont, for dental work
CA2324613A1 (en)Dental implant
RU2691930C2 (en)Implant for covering bone defects in jaw area, as well as method for manufacturing it
US3906549A (en)Implanting structure and method
KR102601368B1 (en) Titanium matrix based tension-free metal warp knitted fabric for guided tissue regeneration
RU2774034C1 (en)Method for forming shut-off device during colostomy in experiment

[8]ページ先頭

©2009-2025 Movatter.jp